PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2511

  1. 742 Posts.
    lightbulb Created with Sketch. 246
    it was and probably still is oversold. PAR is at covid low prices despite advances made to P3.

    im not denying there aren’t any issues. But has it been built into the current price? I’d say so. But isn’t this the million dollar question.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.